Clinical trials
Recruiting Central Nervous System Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Tata Memorial Centre | 3 |
| Children's Oncology Group | 2 |
| Mayo Clinic | 2 |
| Neonc Technologies, Inc. | 2 |
| St. Jude Children's Research Hospital | 2 |
| Weill Medical College of Cornell University | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| Avera McKennan Hospital & University Health Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 56 |
| Brain Neoplasms | 20 |
| Glioma | 15 |
| Neoplasms | 13 |
| Glioblastoma | 9 |
| Breast Neoplasms | 7 |
| Ependymoma | 7 |
| Medulloblastoma | 7 |
| Neoplasms, Germ Cell and Embryonal | 5 |
| Nervous System Neoplasms | 5 |
Trials
Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.